Understanding how CBD affects stress and nicotine withdrawal for smokers
Psychopharmacological effects of cannabidiol on responses to stress and nicotine withdrawal
['FUNDING_R01'] · UNIVERSITY OF MINNESOTA · NIH-11081625
This research looks at how cannabidiol, or CBD, might help people manage stress and withdrawal symptoms when they try to stop smoking.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MINNESOTA (nih funded) |
| Locations | 1 site (MINNEAPOLIS, UNITED STATES) |
| Trial ID | NIH-11081625 on ClinicalTrials.gov |
What this research studies
Many people who try to quit smoking find it difficult because of stress and uncomfortable withdrawal symptoms. This project explores whether cannabidiol (CBD), a compound from cannabis, could help reduce these stress-related changes in the body and mind. Researchers aim to understand how CBD affects your body's stress response and mood, especially during the challenging period of nicotine withdrawal. The ultimate goal is to learn more about how CBD works and if it could be a useful tool to support individuals trying to quit tobacco.
Who could benefit from this research
Good fit: Ideal candidates for future related studies might be adult smokers who are trying to quit and experience significant stress or withdrawal symptoms.
Not a fit: Patients who do not smoke or are not attempting to quit tobacco would likely not receive direct benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new strategies or treatments to help people overcome nicotine addiction by better managing stress and withdrawal symptoms.
How similar studies have performed: While previous work has shown how stress and hormones affect tobacco withdrawal, this specific exploration of CBD's role in managing these symptoms is relatively new.
Where this research is happening
MINNEAPOLIS, UNITED STATES
- UNIVERSITY OF MINNESOTA — MINNEAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: AL'ABSI, MUSTAFA — UNIVERSITY OF MINNESOTA
- Study coordinator: AL'ABSI, MUSTAFA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.